Asymmetry
Draw a line through it and the two halves don't match. Healthy moles are usually symmetrical.
Most melanomas are visible on the skin. Knowing what to look for — and acting quickly — gives treatment its best possible chance. Learn the signs, protect your skin, and check it often.
Melanoma is serious — but it's also one of the most detectable cancers, because it usually shows on the surface of the skin. Time is the variable you can change.
Figures reflect widely published public-health guidance from sources such as the American Cancer Society and the Skin Cancer Foundation. Sentinel is an educational concept and is not affiliated with these organizations; this information is general and does not replace advice from a qualified clinician.
A simple way to remember what to look for in a mole or spot. Any one of these is reason to get it checked — you don't need all five.
Draw a line through it and the two halves don't match. Healthy moles are usually symmetrical.
One edge stays smooth; the other turns ragged and notched. Irregular borders are a flag.
Several distinct shades within one spot — tan, brown, black, sometimes red, white, or blue.
Wider than about 6 mm — a pencil eraser — though melanomas can be smaller.
Changing over time in size, shape, or color — or new itching, bleeding, or crusting.
The "ugly duckling" sign. Trust your instinct about a spot that simply looks different from your other moles, or one that's new or changing. When in doubt, have it checked — it's quick, and almost always reassuring.
UV protection is the clearest lever for skin health. Small habits, done consistently, add up.
Especially between 10 a.m. and 4 p.m., when UV is strongest.
Apply generously and reapply every two hours, or after swimming or sweating.
Wide-brimmed hats, UPF clothing, and UV-blocking sunglasses add real protection.
Indoor tanning meaningfully raises melanoma risk — there's no safe tan.
Get to know your skin so you'll notice when something changes.
Ask how often you should have a professional skin exam for your skin type and history.
Most spots turn out to be harmless. But melanoma is far easier to treat when it's caught early, and a check is quick. You never need a "good enough" reason to ask.
If you have a spot that worries you, contact a doctor or dermatologist. In a medical emergency, call your local emergency number.
Awareness is the first line of defense. Behind it, Sentinel connects clinicians, researchers, and the public around one goal: finding melanoma sooner and improving outcomes for everyone.
Referral guidance, dermoscopy education, and patient-facing materials for your practice.
Explore resourcesPublications, graded sources, and open evidence on early-detection methods.
View researchExplore active screening and imaging trials and check eligibility near you.
See trialsUnderstand what this initiative is, how it works, and how to get involved.
About SentinelIn a well-lit room with a full-length and a hand mirror, look over your whole body. Knowing your own skin is the single most effective habit for catching change early.
Examine your face, scalp, neck, and ears — use a mirror or ask for help with hard-to-see areas.
Chest, torso, underarms, arms, hands and nails, then back, buttocks, and the backs of your legs.
Between toes, soles of the feet, and palms — melanoma can appear where the sun rarely reaches.
Take dated photos to compare over time, and bring concerns to a clinician.
Read plain-language, evidence-graded articles on self-examination, prevention, and what to watch for — free to browse, no account needed.
Short, source-cited explainers on melanoma surveillance, treatment, and self-care — each graded against peer-reviewed evidence. Free to read, no account needed.
A plain-language guide to checkpoint inhibitor immunotherapy — what immune checkpoints are, how PD-1, CTLA-4, and LAG-3 blockade works, what to expect from treatment, and key questions to ask your specialist.
stage IA plain-language guide for patients newly diagnosed with Stage I or Stage II melanoma. Covers what to expect after excision surgery, whether you need a sentinel lymph node biopsy, when adjuvant therapy is recommended, and how follow-up works — including the KEYNOTE-716 trial evidence for adjuvant pembrolizumab in Stage IIB/IIC disease.
uveal melanomaUveal melanoma is a rare eye cancer with historically grim prognosis once it spreads. Tebentafusp (Kimmtrak), approved by the FDA in January 2022, is the first treatment ever shown in a Phase 3 trial to improve overall survival in metastatic uveal melanoma. This article explains what it is, who it is for, and what the evidence shows.
immunotherapyA plain-language guide to Opdualag — the dual LAG-3 + PD-1 checkpoint blockade approved in 2022 for first-line advanced melanoma. What the RELATIVITY-047 trial showed, who it is for, how it compares to other immunotherapy combinations, and what side effects to expect.
treatmentA plain-language guide for newly-diagnosed patients: how melanoma is staged, what the main treatment options are (surgery, immunotherapy, targeted therapy, TIL therapy), and what to expect at each step of the journey.
clinical trialsRecent analysis of patients with clinical stage IIB/IIC melanoma showed that many experience recurrence within five years after surgery alone, underscoring a high risk of disease return [PMID:40908447]. Could delivering immunotherapy before the operation lower that risk? This
Every summary here is built from peer-reviewed sources, each carrying a transparent evidence grade. Browse the library freely, or sign in to keep a private health diary on your own device.
No account needed to read. We store only your Google name and email — no health data, no tracking of what you read.